FAMVIR Drug Patent Profile
✉ Email this page to a colleague
When do Famvir patents expire, and when can generic versions of Famvir launch?
Famvir is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in FAMVIR is famciclovir. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the famciclovir profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Famvir
A generic version of FAMVIR was approved as famciclovir by TEVA PHARMS on August 24th, 2007.
Summary for FAMVIR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Clinical Trials: | 7 |
Patent Applications: | 4,166 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FAMVIR at DailyMed |
Recent Clinical Trials for FAMVIR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
House Research Institute | Phase 3 |
House Clinic, Inc. | Phase 3 |
Novartis | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for FAMVIR
Paragraph IV (Patent) Challenges for FAMVIR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FAMVIR | Tablets | famciclovir | 125 mg, 250 mg and 500 mg | 020363 | 1 | 2004-12-28 |
US Patents and Regulatory Information for FAMVIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-003 | Dec 11, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-001 | Apr 26, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-002 | Jun 29, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FAMVIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-001 | Apr 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-003 | Dec 11, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-003 | Dec 11, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-002 | Jun 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | FAMVIR | famciclovir | TABLET;ORAL | 020363-002 | Jun 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FAMVIR
See the table below for patents covering FAMVIR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S6058982 | GUANINE DERIVATIVE, MANUFACTURE AND PHARMACEUTICAL COMPOSITION | ⤷ Try a Trial |
Cyprus | 2339 | Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections. | ⤷ Try a Trial |
Norway | 972688 | ⤷ Try a Trial | |
Slovakia | 75197 | USE OF AMINOPURINE ANTIVIRAL AGENTS | ⤷ Try a Trial |
Hong Kong | 1003259 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FAMVIR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0141927 | SPC/GB96/014 | United Kingdom | ⤷ Try a Trial | SPC/GB96/014: 20040810, EXPIRES: 20090809 |
0053902 | 96C0036 | Belgium | ⤷ Try a Trial | PRODUCT NAME: FAMCICLOVIR; NAT. REGISTRATION NO/DATE: NL 21325 19960708; FIRST REGISTRATION: GB - 10592/0035 19931210 |
0182024 | SPC/GB94/002 | United Kingdom | ⤷ Try a Trial | SPC/GB94/002: 20050910, EXPIRES: 20081209 |
0141927 | 97C0033 | Belgium | ⤷ Try a Trial | PRODUCT NAME: PENCICLOVIR; NAT. REGISTRATION NO/DATE: 981 IS 110 F 7; 19970206; FIRST REGISTRATION: GB 10592/0078 19960228 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |